TAK-418

Overview

TAK-418 is a selective, orally active LSD1 (KDM1A) enzyme inhibitor with an IC 50 of 2.9 nM. TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Histone Demethylase

Product Information

• Catalog No.: HY-138830
• CAS No.: 1818252-53-7
• Molecular Formula: C17H25ClN2O2S
• Molecular Weight: 356.91
• Purity: 99.81%
• Storage: -20°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 5.5 mg/mL (15.41 mM); Clear solution
• Availability: In-stock

Source

Original product source